RVMD EPS Estimates
Revolution Medicines, Inc.
$193.52
+$5.08(+2.70%)
35
Overall
40
Value
30
Tech
36
Quality
Market Cap
$41.48B
Volume
2.46M
52W Range
$47.45 - $224.31
Target Price
$253.00
RVMD EPS estimates: the consensus estimate for Revolution Medicines, Inc.'s current fiscal year is -$8.98 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RVMD EPS Estimates
- EPS estimate, current quarter
- $-2.33
- EPS estimate, next quarter
- $-2.16
- EPS estimate, current year
- $-8.98
- EPS estimate, next year
- $-6.26
- EPS growth, 3-year
- -24.54%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.95 |
| 2024 | $-3.58 |
| 2023 | $-3.86 |
| 2022 | $-3.08 |
| 2021 | $-2.57 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVMD | $193.52 | +2.7% | 2.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Revolution Medicines, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW